Bluejay Diagnostics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $517.40 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-12
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $248.92K, a 120.10% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $268.48K, a 143.43% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$105.59K.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $33.12K.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $150.92K.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$695.65K.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$30.28K, a 109.00% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $336.62K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $248.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $517.40K 10-Q · filed 2026-08-12 | $411.81K derived: sum of 3 quarters · filed 2026-08-12 | $444.93K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $268.48K 10-Q · filed 2026-05-07 | $162.89K derived: sum of 2 quarters · filed 2026-05-07 | $196.01K derived: sum of 3 quarters · filed 2026-05-07 | $309.11K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$105.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$72.47K derived: sum of 2 quarters · filed 2026-03-06 | $40.63K derived: sum of 3 quarters · filed 2026-08-12 | $150.92K 10-K · filed 2026-03-06 | |||
| 2025-09-30 | $33.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $146.22K derived: sum of 2 quarters · filed 2026-08-12 | $256.51K 10-Q · filed 2025-11-07 | $167.94K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $113.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $223.39K 10-Q · filed 2026-08-12 | $134.83K derived: sum of 3 quarters · filed 2026-08-12 | -$572.54K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $110.29K 10-Q · filed 2026-05-07 | $21.73K derived: sum of 2 quarters · filed 2026-05-07 | -$685.64K derived: sum of 3 quarters · filed 2026-05-07 | -$540.09K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$88.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$795.93K derived: sum of 2 quarters · filed 2026-03-06 | -$650.38K derived: sum of 3 quarters · filed 2026-03-06 | -$695.65K 10-K · filed 2026-03-06 | |||
| 2024-09-30 | -$707.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$561.82K derived: sum of 2 quarters · filed 2025-11-07 | -$607.09K 10-Q · filed 2025-11-07 | -$547.30K 10-Q · filed 2024-11-07 | -$1.57M derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | $145.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $100.28K 10-Q · filed 2025-08-07 | $104.85K 10-Q · filed 2024-08-14 | -$866.94K derived: sum of 3 quarters · filed 2025-08-07 | -$402.98K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | -$45.27K 10-Q · filed 2025-05-13 | -$21.18K 10-Q · filed 2024-05-15 | -$1.01M derived: sum of 2 quarters · filed 2025-05-13 | -$548.53K derived: sum of 3 quarters · filed 2025-05-13 | -$61.39K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$967.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$503.26K derived: sum of 2 quarters · filed 2025-03-31 | -$16.12K derived: sum of 3 quarters · filed 2025-03-31 | -$30.28K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $463.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $951.10K derived: sum of 2 quarters · filed 2024-11-07 | $936.94K 10-Q · filed 2024-11-07 | $823.48K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $487.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $472.98K 10-Q · filed 2024-08-14 | $359.52K derived: sum of 3 quarters · filed 2024-08-14 | $566.66K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$14.16K 10-Q · filed 2024-05-15 | -$127.62K derived: sum of 2 quarters · filed 2024-05-15 | $79.52K derived: sum of 3 quarters · filed 2024-05-15 | $217.24K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$113.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $93.68K derived: sum of 2 quarters · filed 2024-03-28 | $231.40K derived: sum of 3 quarters · filed 2024-03-28 | $336.62K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $207.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $344.86K derived: sum of 2 quarters · filed 2023-11-09 | $450.08K 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $137.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $242.94K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | $105.22K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |